Altimmune, Inc.
CAGE Code: 1ZG60
NCAGE Code: 1ZG60
Status: Active
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 082804936
Summary
Altimmune, Inc. is an Active Commercial Supplier with the Cage Code 1ZG60 and is tracked by Dun & Bradstreet under DUNS Number 082804936..
Address
Suite 201S
910, Clopper Road
Gaithersburg MD 20878-1368
United States
Points of Contact
Related Information
People who viewed this 'CAGE Code' also viewed...
Hypertek Inc Global Satcom Technology Inc Zigler Ari Mainstreet 407 Glazing Llc Jadco Engineering Inc Trevigen, Inc. Row, Klon O Inc Electra Executive Enterprise Inc Roberts Oxygen Co Blackwell Physicians, Llc Peak Technology Cellpoint Scientific, Inc. Dataport Inc Bpt Manufacturing Corporation Skytek Corp Custom Electronics Co Inc Oncor Inc Rockville Office Machines Inc. Orient Express Delivery Service Inc Biomedical Research And Development
Frequently Asked Questions (FAQ) for CAGE 1ZG60
- What is CAGE Code 1ZG60?
- 1ZG60 is the unique identifier used by NATO Organizations to reference the physical entity known as Altimmune, Inc. located at Suite 201S, 910, Clopper Road, Gaithersburg MD 20878-1368, United States.
- Who is CAGE Code 1ZG60?
- 1ZG60 refers to Altimmune, Inc. located at Suite 201S, 910, Clopper Road, Gaithersburg MD 20878-1368, United States.
- Where is CAGE Code 1ZG60 Located?
- CAGE Code 1ZG60 is located in Gaithersburg, MD, USA.
Contracting History for CAGE 1ZG60 Most Recent 25 Records
- HHSN272201400040C
- Development Of Vaccine Formulations Effective Against Niaid Priority Pathogens - Deobligation Of Fy16 Funds
- 2 Sep 2021
- Development Of Vaccine Formulations Effective Against Niaid Priority Pathogens - Deobligation Of Fy16 Funds
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $15,052,879.60
- Department Of Health And Human Services (Hhs)
- HHSN272201400040C
- The Purpose Of This Modification Is To De-Obligate Remaining Fy17 Funds From Line 5 Line 7 And Administratively Close The Contract.
- 2 Jun 2022
- The Purpose Of This Modification Is To De-Obligate Remaining Fy17 Funds From Line 5 Line 7 And Administratively Close The Contract.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $14,720,895.46
- Department Of Health And Human Services (Hhs)
- HHSN272201400040C
- Igf::Ot::Igf Development Of Vaccine Formulations Effective Against Niaid Priority Pathogens
- 13 Dec 2017
- Igf::Ot::Igf Development Of Vaccine Formulations Effective Against Niaid Priority Pathogens
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $15,052,879.60
- Department Of Health And Human Services (Hhs)
- HHSN272201400040C
- The Purpose Of This Modification Is To Cancel Lines 8 And 9 With No Funds And A 2024 Ending Dates Preventing Closeout.
- 13 Jun 2022
- The Purpose Of This Modification Is To Cancel Lines 8 And 9 With No Funds And A 2024 Ending Dates Preventing Closeout.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $14,720,895.46
- Department Of Health And Human Services (Hhs)